Screener
Avalo Therapeutics AVTX Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Avalo Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Avalo Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001534120-26-000049
FAQ
- What is Avalo Therapeutics's asset turnover?
- Avalo Therapeutics (AVTX) reported asset turnover of 0× in Q4 2024.
- How has Avalo Therapeutics's asset turnover changed year-over-year?
- Avalo Therapeutics's asset turnover decreased by 92.8% year-over-year, from 0.1× to 0×.
- What is the long-term trend for Avalo Therapeutics's asset turnover?
- Over 4 years (2020 to 2024), Avalo Therapeutics's asset turnover has grown at a -58.2% compound annual growth rate (CAGR), from 0.2× to 0×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Avalo Therapeutics's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude